Board of Directors

The Alliance Board of Directors is comprised of Principal Investigators (or their designee) from the top 40 accruing Alliance institutions and 10 representatives elected by the Principal Investigators from the remaining main member institutions.

Evanthia Galanis, MD
Group Chair

PRINCIPAL INVESTIGATORS (OR DESIGNEES)
Tareq Al Baghdadi, MD
Trinity Health Saint Joseph Mercy Hospital Ann Arbor
Daniel Almquist, MD
Sanford NCI Community Oncology Research Program
of the North Central Plains
Daniel Anderson, MD, MPH
Metro Minnesota Community Oncology Research Consortium
Adam Asch, MD
University of Oklahoma Health Sciences Center LAPS
Nancy Bartlett, MD
Washington University - Siteman Cancer Center LAPS
Lyudmila Bazhenova, MD
UC San Diego Moores Cancer Center
Judy Boughey, MD
Mayo Clinic
Harold Burstein, MD, PhD
Dana-Farber / Partners CancerCare LAPS
Jay Carlson, DO
Cancer Research for the Ozarks NCORP
Abigail Caudle, MD
MD Anderson Cancer Center
Ki Chung, MD
NCORP of the Carolinas (Prisma Health NCORP)
Alison Conlin, MD
Pacific Cancer Research Consortium NCORP
Jeffrey Crawford, MD
Duke University - Duke Cancer Institute LAPS
Zoneddy Dayao, MD
University of New Mexico Cancer Center
Konstantin Dragnev, MD
Dartmouth College - Dartmouth Cancer Center LAPS
Steven Duffy, MD
Hematology Oncology Associates of Central New York-East Syracuse
Bryan Faller, MD
Heartland Cancer Research NCORP
Darren Feldman, MD
Memorial Sloan Kettering Cancer Center
Bret Friday, MD, PhD
Essentia Health NCI Community Oncology Research Program
Stephen Graziano, MD
State University of New York Upstate Medical University
Seema Harichand-Herdt, MD
Mission Cancer and Blood - Des Moines
William Irvin, MD
Bon Secours Saint Francis Medical Center
Anthony Jaslowski, MD
Wisconsin NCI Community Oncology Research Program
Hedy Kindler, MD
University of Chicago Comprehensive Cancer Center LAPS
Heidi Klepin, MD
Wake Forest University Health Sciences
Jonathan Kolitz, MD
Northwell Health/Center for Advanced Medicine
A. Marilyn Leitch, MD
University of Texas Southwestern Medical Center LAPS
Ellis Levine, MD
Roswell Park Cancer Institute LAPS
Scott Lindhorst, MD
Medical University of South Carolina Minority Underserved NCORP
Gregory Masters, MD
Delaware/Christiana Care NCI Community Oncology Research Program
Matthew Milowsky, MD
UNC Lineberger Comprehensive Cancer Center LAPS
Heather Neuman, MD
University of Wisconsin Carbone Cancer Center
Augusto Ochoa, MD
Gulf South Minority Underserved NCORP
Asit Paul, MD, PhD
VCU Massey Cancer Center Minority Underserved NCORP
Matthew Poppe, MD
University of Utah - Huntsman Cancer Institute LAPS
Kendrith Rowland, MD
Carle Cancer Center NCI Community Oncology Research Program
Matthew Schuchert, MD
UPMC Hillman Cancer Center LAPS
Lewis Silverman, MD
Mount Sinai Hospital
J. Marie Suga, MD, MPH
Kaiser Permanente NCI Community Oncology Research Program
Scott Tagawa, MD
NYP/Weill Cornell Medical Center
Alyssa Throckmorton, MD
Baptist Memorial Health Care/Mid South Minority Underserved NCORP
Claire Verschraegen, MD
Ohio State University Comprehensive Cancer Center LAPS
Shamsuddin Virani, MD
Aurora NCI Community Oncology Research Program
Jamie Wagner, DO, MBA
University of Kansas Cancer Center - MCA Rural MU NCORP
Douglas Weckstein, MD
New Hampshire Oncology Hematology PA-Concord
Matthias Weiss, MD, PhD
Wisconsin NCI Community Oncology Research Program
William Wilson, MD
Adena Regional Medical Center
Tina Yen, MD
Froedtert and the Medical College of Wisconsin LAPS
Kathleen Yost, MD
Cancer Research Consortium of West Michigan NCORP

FORMER GROUP CHAIRS
Monica M. Bertagnolli, MD
National Institutes of Health
Suzanne George, MD
Dana-Farber Cancer Institute
James N. Ingle, MD
Mayo Clinic
Heidi Nelson, MD
Mayo Clinic
David Ota, MD
Duke University Medical Center
Richard L. Schilsky, MD
University of Chicago Comprehensive Cancer Center
Samuel A. Wells Jr., MD
National Institutes of Health

MODALITY COMMITTEE CHAIRS
Jeffrey Bogart, MD
State University of New York Upstate Medical University
Jennifer Dill, CCRP
Southeast Cancer Center
Lisa Kottschade, RN, MSN, CNP
Mayo Clinic
David Kozono, MD, PhD
Dana-Farber/Harvard Cancer Center
Michael Linden, MD, PhD
University of Minnesota/Masonic Cancer Center
Andrew Nixon, PhD, MBA
Duke University Medical Center
Miguel-Angel Perales, MD
Memorial Sloan Kettering Cancer Center
Lawrence H. Schwartz, MD
Memorial Sloan Kettering Cancer Center

PROGRAM PRINCIPAL INVESTIGATORS
Isabelle Bedrosian, MD
Procedure-Based Therapy Program
Olwen Hahn, MD
Central Protocol Operations Program
Sumithra Mandrekar, PhD
Statistics and Data Management Program
Electra Paskett, PhD
Cancer Control Program
W. Fraser Symmans, MD
Translational Research Program